You searched for "age"

1258 results found

From the editor Nov/Dec 2025

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. TW / X: @Voicedoctor_uk For ENT&A Nov/Dec2025, we are delighted to celebrate the remarkable educational institution ENT Masterclass®, which marks its 20th anniversary with...

Young CEORL-HNS: empowering the future of otorhinolaryngology

Young CEORL-HNS is a subgroup within CEORL-HNS which encompasses new specialists in ENT within training and up to the first decade or so as an accredited specialist. Giuditta Mannelli is the current president and is a head and neck surgeon...

‘Drop-in’ nasendoscopy – a decade of development to find head and neck cancer early

A decade of innovation in digital, remote endoscopy is paving the way for ‘drop-in’ nasendoscopy, improving early head and neck cancer diagnosis in high-risk communities. In May 2026, the University Hospitals North Midlands (UHNM) will inaugurate its newly established clinical...

From the editor MarApr 2020

Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net As I write this editorial, the world is holding its breath while it follows the coronavirus...

Is there increased cardiovascular risk with macrolide antibiotics?

This month’s Ed’s Choice delightfully reviews the potential cardiovascular consequences of long-term macrolide use in the treatment of chronic rhinosinusitis. This used to be one of my ‘go-to’ topics of conversation at home after a bad day at work, although...

Dupilumab prospective RCT for CRSwNP, a multinational trial of 60 patients with a 16-week CT follow-up

This transcontinental work describes a randomised, double blind, placebo controlled parallel group study over a 16-week period, assessing 60 patients with CRSwNP by CT scan scores. All patients had a four-week period of intranasal corticosteroids followed by randomisation to add...

Oticon Medical announces (FDA) clearance and CE mark of its first active transcutaneous bone conduction hearing system, the Sentio™ System.

The Sentio System delivers the proven benefits of the Ponto™ System – and more – in a transcutaneous option.

Robotic‑assisted cochlear implant insertion approved by FDA

The Minnesota-based medical technology company iotaMotion has announced a "meaningful milestone in peadiatric hearing care", having received clearance from the US Food and Drug Administration (FDA) for the iotaSoft® robotic‑assisted cochlear implant insertion system for children aged four and older.

Peter McKelvie 1932 – 2026

Peter McKelvie, an outstanding head & neck surgeon and oncologist, died on 6 February aged 93. He suffered a spontaneous subdural haemorrhage. British otolaryngology has lost the most remarkable talent of his generation. He combined a prodigious intellect with effortless...

Hidden genetic disorders in children that may present to the otolaryngologist

Background Among the many hundreds of children presenting to the otolaryngology clinic are a few whose symptoms are due to an underlying genetic condition. In most cases the underlying syndrome is obvious and has already been diagnosed, such as the...

Barrier and opportunities for hearing care: finding a way forward for all

Ideal models of care for communities can include tailored ear and hearing care interventions. Barriers exist at an individual and societal level to realise the vision of hearing care for all, regardless of country or resource setting. Affordability of hearing...

Taking life by the throat

Patients suffering with problems with their voice, airway and/or swallowing can find their symptoms immensely distressing, and their care places a huge burden on healthcare systems. We hear from a world-leading laryngologist on current and future directions. Field of interest...